[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370347-105":59,"doc-detail-370347-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-model-is-an-effective-means-to-diagnose-benign-and-malignant-pulmonary-nodules","Multi-omics model is an effective means to diagnose benign and malignant pulmonary nodules","","To address the high false-positive rate of traditional Low-Dose Computed Tomography (LDCT) in diagnosing pulmonary malignant nodules, this retrospective study evaluates whether blood-based noninvasive metabolite detection combined with artificial-intelligence imaging scoring improves clinical diagnosis of pulmonary nodules. Risk scoring was performed in patients positive for pulmonary nodules, followed by invasive sampling and pathological examinations as the gold standard. Among 210 patients (23 benign, 187 malignant), multi-omics showed stronger overall performance than single models, with AUC of 0.823, supporting better non-invasive discrimination of malignant nodules.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-model-is-an-effective-means-to-diagnose-benign-and-malignant-pulmonary-nodules/370347/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-model-is-an-effective-means-to-diagnose-benign-and-malignant-pulmonary-nodules/370347.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":8},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study target in pulmonary nodule diagnosis?","Question",{"text":112,"@type":113},"It targets the high false-positive rate of traditional Low-Dose Computed Tomography (LDCT) when distinguishing malignant from benign pulmonary nodules, especially for small nodules with indistinguishable CT features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the diagnostic gold standard established?",{"text":117,"@type":113},"After risk scoring of patients positive for pulmonary nodules, invasive procedures were used to sample nodules and perform pathological examinations, which served as the gold standard.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the main effectiveness result of the multi-omics model?",{"text":121,"@type":113},"The multi-omics model demonstrated an AUC of 0.823 and showed better overall performance than single-model approaches for non-invasive diagnosis of malignant pulmonary nodules.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370347,1790188141,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":8,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":129,"read_time":143,"preview_page_count":19,"preview_urls":144},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Clinics 80 (2025) 100599  \nContents lists available at ScienceDirect  \nClinics  \njournal [homepage:](homepage: www.elsevier.com/locate/clinsp)[ www.elsevier.com/locate/clinsp](homepage: www.elsevier.com/locate/clinsp)  \n| Original articles\u003Cbr>Multi-omics model is an effective means to diagnose benign and malignant pulmonary nodules\u003Cbr>Yunzeng Zhang a,b,1 , Fan Zhang a,1 , Changming Shena , Gaofeng Qiao a , Cheng Wang a , Feng Jin a,c , Xiaogang Zhao b,* \u003Cbr>a Department of Thoracic Surgery, Shandong Public Health Clinical Center, Shandong University, Shandong, China b Department of Thoracic Surgery, The Second Hospital of Shandong University, Jinan, Shandong, China c Provincial Key Laboratory for Respiratory Infectious Diseases in Shandong, Shandong University, Shandong, China |  |  | |\n| --- | --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Multi-omics model Diagnose\u003Cbr>Benign\u003Cbr>Malignant Pulmonary nodules |  | In response to the high false positive rate of traditional Low-Dose Computed Tomography (LDCT) in diagnosing pulmonary malignant nodules, this study aimed to investigate the effectiveness of scoring of blood-based noninvasive biological metabolite detection combined with artificial intelligent scoring of non-invasive imaging in the clinical diagnosis of Pulmonary Nodules (PNs). In this retrospective study, risk scoring was performed inpatients positive for pulmonary nodules and subsequently, PNs were sampled by invasive procedures for pathological examinations. The pathological classification was used as the gold standard, and statistical and machine learning methods showed, that in 210 patients (23 benign PN and 187 malignant PN), the risk score of Metabonomics, radiomics, and multi-omics had different levels of performance in different risk groups based on various predictive models. The Area Under the receiver operating Characteristic Curve (AUC) of the multi-omics model was 0.823. The present results indicate that a multi-omics model is more effective than a single model in the non-invasive diagnosis of pulmonary malignant nodules. |  |\n\nBackground  \nLung cancer is a malignant tumor with the highest incidence and mortality in China and has been the greatest threat to human health and life.1 Due to the insidious early symptoms, 60 %‒80 % of lung cancer is often diagnosed at the advanced stage, and thus the 5-year survival rate of lung cancer patients is only about 5.6 %..2 Therefore, early diagnosis and treatment of lung cancer is an effective way to reduce the mortality of lung cancer and improve the survival of lung cancer patients.  \nCurrently, Low Dose Computed Tomography (LDCT) is the most widely used tool for the screening of lung cancer. However, for patients with small pulmonary nodules, distinguishing between malignant and benign nodules by using Computed Tomography (CT) has been a challenge in clinical practice, as radiological features are indistinguishable between malignant and benign nodules.3 To date, some biomarkers have been employed for the diagnosis of tumors, but most of these proteins are also present in the serum of cancer-free patients, which limits their clinical application in the early diagnosis of cancers.4 Some studies have  \nreported that small molecule substances such as free amino acids, free fatty acids, and phospholipids in the serum exhibit significant differences between cancer patients and healthy controls, and serum is preferred for metabolomics studies.5,6 However, many biomarkers that are widely used to assess the risk of cancers usually have a low specificity.7 Only a few studies report the use of serum markers in the screening and diagnosis of cancers,8–10 and studies on these markers are still ongoing. Thus, clinical studies are facing challenges in the real world, and the results show significant differences among various studies. Silverstri et al.11 developed a model that could distinguish benign and malignant pulmonary nodules based on pr","cbCaiaYkl4TGScJj","https://ap.wps.com/l/cbCaiaYkl4TGScJj","pdf",2451400,"English","# Background\n## Clinical need and limitations of LDCT\n## Biomarkers and metabolomics rationale\n# Study Aim\n# Methods and Materials\n## Retrospective design and patient workflow\n## Gold standard and modeling approach\n# Results\n## Performance across benign/malignant risk groups\n## AUC of the multi-omics model\n# Conclusion","[{\"question\":\"What problem does the study target in pulmonary nodule diagnosis?\",\"answer\":\"It targets the high false-positive rate of traditional Low-Dose Computed Tomography (LDCT) when distinguishing malignant from benign pulmonary nodules, especially for small nodules with indistinguishable CT features.\"},{\"question\":\"How was the diagnostic gold standard established?\",\"answer\":\"After risk scoring of patients positive for pulmonary nodules, invasive procedures were used to sample nodules and perform pathological examinations, which served as the gold standard.\"},{\"question\":\"What was the main effectiveness result of the multi-omics model?\",\"answer\":\"The multi-omics model demonstrated an AUC of 0.823 and showed better overall performance than single-model approaches for non-invasive diagnosis of malignant pulmonary nodules.\"}]","Multi-omics model is an effective means to diagnose benign and malignant pulmonary nodules | PDF",13,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6caab31292ddb2b9084432875851249.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a8ca8d505aae60d0905f6b866cca243.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/342bb31202137374bc330ad098a5e952.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c87217508ff959e62e039cc2c13e0f35.webp",980,1306]